Innovating the buccal micronucleus cytome assay to improve its utility as a biomarker of in vivo genotoxicity
Mutagenesis · 26.03.2026 · 41 (1-2) · 28-36
DOI: 10.1093/mutage/geaf023 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Mutagenesis, online erschienen am 17.10.2025. Verfasst von Michael Fenech und 4 weiteren Autor:innen. Beteiligte Einrichtung: Genome Health Foundation, 25, King George Avenue, North Brighton, SA, 5048, Australia. Hauptthemen laut MEDLINE: Mouth Mucosa, DNA Damage, Mutagens, Micronuclei, Chromosome-Defective. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben.
Abstract (Originalsprache)
The Buccal Micronucleus Cytome (B-MNcyt) assay is used worldwide to study chromosomal abnormalities and environmental genotoxicity and cytotoxicity in humans. The aim of this article is to discuss the strengths and limitations of the B-MNcyt assay and to identify emerging opportunities to further improve and validate its use. This can be achieved by innovating and evolving the B-MNcyt assay by identifying and solving important knowledge and technological gaps that hinder its utility. The cells examined in the B-MNcyt assay are squamous epithelial cells that can be easily collected from the inside of the mouth. These cells are postmitotic cells generated from the proliferative basal layer and may contain micronuclei (MN). MN can be generated during mitosis of the basal cells prior to their differentiation into squamous cells. The B-MNcyt assay is increasingly being used to measure DNA damage induced in vivo by environmental genotoxins. Results with this assay have been shown to correlate positively with MN frequency measured using the well-validated lymphocyte cytokinesis-block micronucleus cytome (L-CBMNcyt) assay. However, the B-MNcyt assay has some important limitations that need to be addressed to achieve a similar level of validation and applicability to that of the L-CBMNcyt assay. These include the lack of (i) evidence that the buccal MN frequency predicts disease risk in prospective studies; (ii) an automated scoring system to score MN in buccal cells, which is essential to achieve statistically robust results and to improve the feasibility of the assay in population studies; (iii) sufficient research on the kinetics of MN expression in buccal cells to define optimal time frames to score MN after acute exposure or during chronic genotoxin exposure; and (iv) studies to test the suitability of using the B-MNcyt assay for radiation exposure biodosimetry. This article discusses these issues and provides some suggestions on how to address them.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Genome Health Foundation, 25, King George Avenue, North Brighton, SA, 5048, Australia.
- Environmental Carcinogenesis Unit, Ospedale Policlinico San Martino, Genoa, Italy.
- Center for Cancer Research, Medical University of Vienna, Borschkegasse 8a, A-1090 Vienna, Austria.
- Unit of Clinical and Molecular Epidemiology, IRCCS San Raffaele, Via di val Cannuta 247, 001166, Rome, Italy.
- Department of Human Sciences and Quality of Life Promotion, San Raffaele University, Via di Val Cannuta, 247 00166 Rome, Italy.
Zitieren
APA
Fenech, M., Bolognesi, C., Nersesyan, A., Knasmueller, S., & Bonassi, S. (2026). Innovating the buccal micronucleus cytome assay to improve its utility as a biomarker of in vivo genotoxicity. Mutagenesis, 41(1-2), 28-36. https://doi.org/10.1093/mutage/geaf023
Vancouver
Fenech M, Bolognesi C, Nersesyan A, Knasmueller S, Bonassi S. Innovating the buccal micronucleus cytome assay to improve its utility as a biomarker of in vivo genotoxicity. Mutagenesis. 2026;41(1-2):28-36. doi:10.1093/mutage/geaf023
BibTeX
@article{Fenech2026,
author = {Fenech, Michael and Bolognesi, Claudia and Nersesyan, Armen and Knasmueller, Siegfried and Bonassi, Stefano},
title = {Innovating the buccal micronucleus cytome assay to improve its utility as a biomarker of in vivo genotoxicity},
journal = {Mutagenesis},
year = {2026},
volume = {41},
number = {1-2},
pages = {28--36},
doi = {10.1093/mutage/geaf023}
}
EUVIMED